Efficacy and tolerability of moxifloxacin and clindamycin in patients with peridontal abscesses or inflammatory infiltrates.

Trial Profile

Efficacy and tolerability of moxifloxacin and clindamycin in patients with peridontal abscesses or inflammatory infiltrates.

Completed
Phase of Trial: Phase II

Latest Information Update: 10 May 2011

At a glance

  • Drugs Clindamycin; Moxifloxacin
  • Indications Bacterial infections; Periodontal abscess
  • Focus Therapeutic Use
  • Acronyms MOCLI
  • Most Recent Events

    • 10 May 2011 Microbiological (secondary endpoint) results presented at the 21st European Congress of Clinical Microbiology and Infectious Diseases and the 27th International Congress of Chemotherapy.
    • 05 Nov 2010 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top